Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO

On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environments

PETACH TIKVA, Israel – August 10 – Nanox AI Ltd., a subsidiary of Nano-X Imaging Ltd. (NASDAQ: NNOX), today announced the optimization of its medical imaging AI application framework for Intel CoreUltra processors using Intel’s OpenVINO toolkit. The framework is designed to support AI applications running on an on-premise edge device within healthcare facilities, enabling organizations to evaluate and deploy CT imaging AI applications while keeping imaging data within their own infrastructure.